Cost per responder for methotrexate versus other therapies in patients with moderate-to-severe plaque psoriasis in Italy
Objective: Conventional synthetic disease modifying antirheumatic drugs (csDMARDs) were recommended in 2019 as first line therapy from Italian Medicines Agency (AIFA) for the treatment of moderate to severe psoriasis. Updated local guidelines recommended methotrexate (MTX) as the drug of first choic...
Kaydedildi:
| Asıl Yazarlar: | , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
AboutScience Srl
2022-11-01
|
| Seri Bilgileri: | Global & Regional Health Technology Assessment |
| Konular: | |
| Online Erişim: | https://journals.aboutscience.eu/index.php/grhta/article/view/2474 |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|